Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Spada

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Ecancermedicalscience|December 11, 2012
Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumoursFrancesca Spada, Nicola Fazio, Guido Bonomo, et al.
Cancers|October 16, 2024
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine NeoplasmsCatarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Updates in Surgery|February 28, 2022
Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumorsEmilio Bertani, Fabio Zugni, Davide Radice, et al.
Current Oncology Reports|March 9, 2022
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to BedsideMaria João de Sousa, Lorenzo Gervaso, Monica Isabel Meneses-Medina, et al.
Prenatal Diagnosis|March 18, 2014
Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosisPaola Battaglia, Anna Baroncini, Angela Mattarozzi, et al.
Pancreas|January 19, 2017
Everolimus in Pancreatic Neuroendocrine Carcinomas G3Francesco Panzuto, Maria Rinzivillo, Francesca Spada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?Vito Amoroso, Nicola Fazio, Alessandra Mosca, et al.
Annals of Surgical Oncology|December 3, 2024
Surgical and Oncologic Outcomes of Primary Tumor Resection in Patients with Small Intestinal Neuroendocrine Tumors: Results from a Single-Center Series Over a 15-Year PeriodMaria Danieli, Uberto Fumagalli Romario, Davide Radice, et al.
Annals of Surgical Oncology|December 26, 2024
ASO Visual Abstract: Surgical and Oncologic Outcomes of Primary Tumor Resection in Patients with Small Intestinal Neuroendocrine Tumors: Results from a Single-Center Series Over a 15-Year PeriodMaria Danieli, Uberto Fumagalli Romario, Davide Radice, et al.
Cancer Treatment Reviews|September 23, 2019
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysisTaiane F Rebelatto, Maicon Falavigna, Marta Pozzari, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Ecancermedicalscience|December 11, 2012
Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumoursFrancesca Spada, Nicola Fazio, Guido Bonomo, et al.
Cancers|October 16, 2024
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine NeoplasmsCatarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Updates in Surgery|February 28, 2022
Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumorsEmilio Bertani, Fabio Zugni, Davide Radice, et al.
Current Oncology Reports|March 9, 2022
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to BedsideMaria João de Sousa, Lorenzo Gervaso, Monica Isabel Meneses-Medina, et al.
Prenatal Diagnosis|March 18, 2014
Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosisPaola Battaglia, Anna Baroncini, Angela Mattarozzi, et al.
Pancreas|January 19, 2017
Everolimus in Pancreatic Neuroendocrine Carcinomas G3Francesco Panzuto, Maria Rinzivillo, Francesca Spada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?Vito Amoroso, Nicola Fazio, Alessandra Mosca, et al.
Annals of Surgical Oncology|December 3, 2024
Surgical and Oncologic Outcomes of Primary Tumor Resection in Patients with Small Intestinal Neuroendocrine Tumors: Results from a Single-Center Series Over a 15-Year PeriodMaria Danieli, Uberto Fumagalli Romario, Davide Radice, et al.
Annals of Surgical Oncology|December 26, 2024
ASO Visual Abstract: Surgical and Oncologic Outcomes of Primary Tumor Resection in Patients with Small Intestinal Neuroendocrine Tumors: Results from a Single-Center Series Over a 15-Year PeriodMaria Danieli, Uberto Fumagalli Romario, Davide Radice, et al.
Cancer Treatment Reviews|September 23, 2019
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysisTaiane F Rebelatto, Maicon Falavigna, Marta Pozzari, et al.
Pageof 12